Kenyan Research Agency Says Ebola Vaccine Safe, Effective

Edited by Ivan Martínez
2015-04-03 12:49:51

Pinterest
Telegram
Linkedin
WhatsApp

Nairobi, April 3 (Xinhua) -- A candidate Ebola vaccine has demonstrated a high degree of efficacy, safety and could deal a final blow to the hemorrhagic fever that has killed some 10,000 people in West Africa.

Results from the phase one trial of the Ebola vaccine rVSV ZEBOV released by Kenya's Medical Research Institute (KEMRI) on Thursday revealed its capacity to protect humans from the killer disease.



Commentaries


MAKE A COMMENT
All fields required
NOT TO BE PUBLISHED
captcha challenge
up